close to that of the cerebrospinal fluid in some parts. All of these results were consistent with a clinical diagnosis of VWM [1, 4] . In addition, the disease progression was very slow, and her clinical state remained nearly stable for several years.
A genetic analysis was performed, using a method previously described [6] . In brief, DNA was extracted from a blood sample after obtaining informed consent from the patient. The entire coding regions of EIF2B2 and EIF2B5, which encode eIF2B ␤ and eIF2B , respectively, Dear Sir, Leukoencephalopathy with vanishing white matter (VWM) [1] , also referred to as childhood ataxia with diffuse central nervous system hypomyelination (CACH) [2] , is a newly described white matter disease characterized by autosomal recessive inheritance, chronic progressive cerebellar ataxia, spasticity and unique MRI findings. Recently, mutations in the 5 genes (EIF2B1 to EIF2B5) encoding the subunits of the eukaryotic translation initiation factor 2B (eIF2B), which plays an important role in the regulation of translation initiation of protein synthesis, have been identified as the cause of VWM [3, 4] . We previously reported the first case of adult-onset VWM of Asian origin based on clinical diagnostic criteria [5] . Herein, we report the findings of a genetic study of this case that identified a novel EIF2B mutation.
Our female patient developed slowly progressive gait disturbance and hand clumsiness at the age of 42 [5] . Neurological findings included cerebellar ataxia, exaggerated deep tendon reflexes with bilateral Babinski sign and mild mental decline. Cranial MRI showed that the cerebral white matter was symmetrically and diffusely abnormal with a signal intensity were amplified using the PCR primer sets listed at http://www.vumc.nl/whitematter. After purification of the PCR products, direct sequencing was performed using an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, Calif., USA). The result revealed a novel G1459A missense mutation in the EIF2B5 gene ( fig. 1 A) . This mutation in EIF2B5 leads to a substitution of glutamic acid for lysine in eIF2B at position 487 (E487K). Forty-four unrelated Japanese control subjects did not show this mutation ( fig. 1 B) . There are 77 different mutations in EIF2B that have been described thus far in 148 VWM/CACH patients, most of which are missense mutations [7] . In adult-onset cases, R113H [8] and T182M [6] in eIF2B have been reported. No apparent correlation has been found between the affected subunits and disease severity, though correlations between certain mutations at the homozygous state and the age of disease onset and severity have been reported [7] . Further, VWM/CACH patients with the homozygous mutation, R113H in eIF2B [8, 9] and E213G in eIF2B ␤ [9] have been shown to express milder forms of the disease. In our patient, the age at disease onset was relatively advanced, and the clinical course has been apparently mild to date. It remains to be determined whether the novel EIF2B mutation identified in this case is associated with a milder form of VWM/CACH.
